Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

Gynecologic Oncology

Volumn 124, Issue 1, 2012, Pages 142-147

  Elattar, Ahmed ^a,b   Warburton, Katharine G ^b   Mukhopadhyay, Asima ^a,b   Freer, Rebecca M ^b   Shaheen, Fadhel ^b   Cross, Paul ^a   Plummer, E Ruth ^b   Robson, Craig N ^b   Edmondson, Richard J ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Androgen receptor; Anti androgens; Epithelial ovarian cancer; Tissue microarray

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CARBOPLATIN; MESSENGER RNA; PACLITAXEL;

ADD ON THERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; APOPTOSIS; ARTICLE; ASCITES FLUID; CAG REPEAT; CANCER CELL CULTURE; CANCER GRADING; CANCER PATIENT; CANCER RELAPSE; CELL CYCLE S PHASE; CELL DIVISION; CELL FRACTIONATION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE MARKER; DRUG EXPOSURE; EPITHELIUM CELL; EXON; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ANDROGENS; ASCITIC FLUID; CYSTADENOCARCINOMA, SEROUS; DIHYDROTESTOSTERONE; EXONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASMS, HORMONE-DEPENDENT; OVARIAN NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER; S PHASE; STIMULATION, CHEMICAL; TRINUCLEOTIDE REPEATS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 83055172671     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.004     Document Type: Article

References (25)

1. R. Scully Pathology of ovarian cancer precursors J Cell Biochem 23 Suppl 1995 208 218 (Pubitemid 26032877)
2. J.M. Schildkraut Epithelial ovarian cancer risk among women with polycystic ovary syndrome Obstet Gynecol 88 4 I 1996 554 559 (Pubitemid 26326017)
3. E.L. Wynder Epidemiology of cancer of the ovary Cancer 23 2 1969 352 370
4. A.C. Sonnichsen Obesity, body fat distribution and the incidence of breast, cervical, endometrial and ovarian carcinomas Dtsch Med Wochenschr 115 50 1990 1906 1910
5. K. Helzlsouer Serum gonadotrophins and steroid hormones and the development of ovarian cancer JAMA 274 1995 1926 1930 (Pubitemid 26003062)
6. C.-G. Mahlck Androstenedione production by malignant epithelial ovarian tumours Gynecol Oncol 25 1986 217 222 (Pubitemid 16004358)
7. M.R. Cardillo Androgen receptors in ovarian tumors: correlation with estrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study J Exp Clin Cancer Res 17 2 1998 231 237 (Pubitemid 28335584)
8. R.J. Edmondson The human ovarian surface epithelium is an androgen responsive tissue Br J Cancer 86 6 2002 879 885 (Pubitemid 34271022)
9. V. Syed Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells Cancer Res 61 18 2001 6768 6776 (Pubitemid 32896499)
10. A. Evangelou Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells Cancer Res 60 4 2000 929 935 (Pubitemid 30129528)
11. L.A. Sheach Androgen-related expression of G-proteins in ovarian cancer Br J Cancer 101 3 2009 498 503
12. S. Tumolo Phase 2 trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study Eur J Cancer 30A 7 1994 911 914 (Pubitemid 24256232)
13. M. Vassilomanolakis A phase II study of flutamide in ovarian cancer Oncology 54 3 1997 199 202 (Pubitemid 27160585)
14. D. Levine A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission Cancer 110 11 2007 2458 2466
15. A. Mukhopadhyay Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-Ribose) polymerase inhibitors Clin Cancer Res 16 8 2010 2344 2351
16. T.G. Shepherd Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients Nat Protoc 1 6 2007 2643 2649
17. W.P. McGuire III, and M. Markman Primary ovarian cancer chemotherapy: current standards of care Br J Cancer 89 S3 2003 S3 S8 (Pubitemid 38067997)
18. R.L. Camp Validation of tissue microarray technology in breast carcinoma Lab Invest 80 2000 1943 1949 (Pubitemid 32012762)
19. R. Leake Immunohistochemical detection of steroid receptors in breast cancer: a working protocol J Clin Pathol 53 8 2000 634 635 (Pubitemid 30640178)
20. D.A. Levine, and J. Boyd The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series Cancer Res 61 3 2001 908 911 (Pubitemid 32174401)
21. N. Chamberlain The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function Nucl Acids Res 22 15 1994 3181 3186 (Pubitemid 24260654)
22. D. Levine A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission Cancer 110 11 2007 2448 2456 (Pubitemid 350174930)
23. T.S. Mantoni Androgen receptor activity is inhibited in response to genotoxic agents in a p53-independent manner Oncogene 25 22 2006 3139 3149 (Pubitemid 43881555)
24. L. Gan Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer Cancer Res 69 21 2009 8386 8394
25. K. Kuroda Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy Prostate 69 14 2009 1579 1585